145 related articles for article (PubMed ID: 1373964)
1. A retrospective study on the patterns of sequential fluctuation of serum alpha-fetoprotein level during progression from liver cirrhosis to hepatocellular carcinoma.
Imaeda T; Doi H
J Gastroenterol Hepatol; 1992; 7(2):132-5. PubMed ID: 1373964
[TBL] [Abstract][Full Text] [Related]
2. Serial changes in serum alpha-fetoprotein prior to detection of hepatocellular carcinoma in liver cirrhosis.
Kuwahara T; Sakai T; Majima Y; Hirai K; Tanikawa K
Hepatogastroenterology; 1993 Aug; 40(4):347-51. PubMed ID: 7691701
[TBL] [Abstract][Full Text] [Related]
3. The progressive elevation of alpha fetoprotein for the diagnosis of hepatocellular carcinoma in patients with liver cirrhosis.
Arrieta O; Cacho B; Morales-Espinosa D; Ruelas-Villavicencio A; Flores-Estrada D; Hernández-Pedro N
BMC Cancer; 2007 Feb; 7():28. PubMed ID: 17288606
[TBL] [Abstract][Full Text] [Related]
4. Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma.
Oka H; Tamori A; Kuroki T; Kobayashi K; Yamamoto S
Hepatology; 1994 Jan; 19(1):61-6. PubMed ID: 7506227
[TBL] [Abstract][Full Text] [Related]
5. Extreme elevation of serum alpha fetoprotein in decompensated cirrhosis without HCC: an ominous sign.
Senturk H; Cumali R
Int J Biol Markers; 2007; 22(1):19-23. PubMed ID: 17393357
[TBL] [Abstract][Full Text] [Related]
6. Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein.
Sato Y; Nakata K; Kato Y; Shima M; Ishii N; Koji T; Taketa K; Endo Y; Nagataki S
N Engl J Med; 1993 Jun; 328(25):1802-6. PubMed ID: 7684823
[TBL] [Abstract][Full Text] [Related]
7. Sequential fluctuation pattern of serum des-gamma-carboxy prothrombin levels detected by high-sensitive electrochemiluminescence system as an early predictive marker for hepatocellular carcinoma in patients with cirrhosis.
Shimizu A; Shiraki K; Ito T; Sugimoto K; Sakai T; Ohmori S; Murata K; Takase K; Tameda Y; Nakano T
Int J Mol Med; 2002 Mar; 9(3):245-50. PubMed ID: 11836630
[TBL] [Abstract][Full Text] [Related]
8. alpha-Fetoprotein screening in patients with idiopathic hemochromatosis and liver cirrhosis.
Chayvialle JA; Brissot P; Pelletier MJ; Hita de Nercy Y; Lambert R; Bourel M
Digestion; 1977; 16(1-2):118-27. PubMed ID: 79512
[TBL] [Abstract][Full Text] [Related]
9. Fucosylation index of alpha-fetoprotein, a possible aid in the early recognition of hepatocellular carcinoma in patients with cirrhosis.
Aoyagi Y; Saitoh A; Suzuki Y; Igarashi K; Oguro M; Yokota T; Mori S; Suda T; Isemura M; Asakura H
Hepatology; 1993 Jan; 17(1):50-2. PubMed ID: 7678576
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular Carcinoma Screening Utilising Serum Alpha-Fetoprotein Measurement and Abdominal Ultrasound Is More Effective than Ultrasound Alone in Patients with Non-viral Cirrhosis.
Worland T; Harrison B; Delmenico L; Dowling D
J Gastrointest Cancer; 2018 Dec; 49(4):476-480. PubMed ID: 28920172
[TBL] [Abstract][Full Text] [Related]
11. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
Liu X; Chi X; Gong Q; Gao L; Niu Y; Chi X; Cheng M; Si Y; Wang M; Zhong J; Niu J; Yang W
PLoS One; 2015; 10(5):e0127518. PubMed ID: 25996938
[TBL] [Abstract][Full Text] [Related]
12. Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis.
Giannini EG; Marenco S; Borgonovo G; Savarino V; Farinati F; Del Poggio P; Rapaccini GL; Anna Di Nolfo M; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F;
Hepatology; 2012 Oct; 56(4):1371-9. PubMed ID: 22535689
[TBL] [Abstract][Full Text] [Related]
13. Serum transforming growth factor alpha level as a marker of hepatocellular carcinoma complicating cirrhosis.
Tomiya T; Fujiwara K
Cancer; 1996 Mar; 77(6):1056-60. PubMed ID: 8635123
[TBL] [Abstract][Full Text] [Related]
14. Corelation of serum alpha fetoprotein and tumor size in hepatocellular carcinoma.
Abbasi A; Bhutto AR; Butt N; Munir SM
J Pak Med Assoc; 2012 Jan; 62(1):33-6. PubMed ID: 22352098
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the Clinical Utility of Glypican 3 as a Serum Marker for the Diagnosis of Hepatocellular Carcinoma.
Jia X; Gao Y; Zhai D; Liu J; Cai J; Wang Y; Jing L; Du Z
Technol Cancer Res Treat; 2016 Dec; 15(6):780-786. PubMed ID: 26370140
[TBL] [Abstract][Full Text] [Related]
16. [Focus on a new assay of fucosylated alpha-fetoprotein and evaluation in the biological diagnosis of hepatocellular carcinoma in cirrhosis].
Denis I; Beaudonnet A; Pichot J; Roubille M; Gelineau M
Ann Biol Clin (Paris); 2000; 58(1):85-90. PubMed ID: 10673618
[No Abstract] [Full Text] [Related]
17. Clinical observations during a relatively early stage of hepatocellular carcinoma, with special reference to serum alpha-fetoprotein levels.
Okuda K; Kotoda K; Obata H; Hayashi N; Hisamitsu T
Gastroenterology; 1975 Jul; 69(1):226-34. PubMed ID: 50251
[TBL] [Abstract][Full Text] [Related]
18. The clinical value of serum ferritin in hepatocellular carcinoma.
Simonetti RG; Craxi A; Dardanonì G; Lanzarone F; Barbaria F; Cottone M; Pagliaro L
Hepatogastroenterology; 1985 Dec; 32(6):276-8. PubMed ID: 2419233
[TBL] [Abstract][Full Text] [Related]
19. Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis.
Oka H; Kurioka N; Kim K; Kanno T; Kuroki T; Mizoguchi Y; Kobayashi K
Hepatology; 1990 Oct; 12(4 Pt 1):680-7. PubMed ID: 1698703
[TBL] [Abstract][Full Text] [Related]
20. Value of serum protective activity against acid precipitation of poly (U) in the differentiation between cirrhotic patients with and without hepatocellular carcinoma.
Kouretas D; Kountouras J; Tsapas G; Anastasiades N; Tsakiri I; Antonoglou O
Anticancer Res; 1990; 10(4):1025-8. PubMed ID: 1696444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
